EGR2 and gastric cancer: In conclusion, we found that a high expression of miR-25 in BGC823 gastric cancer cells can enhance cell growth and reduce cell apoptosis via targeting gene EGR2. The result revealed that miR-25 might be a potential therapeutic target for gastric cancer.